Clinical Trial Update: A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance [Phase 3]

View source ↗

Summary

This Clinical Trial Update notes a Phase III confirmatory study of pemafibrate (K-877) for hypercholesterolemia in statin-intolerant patients, with the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Pemafibrate (pemafibrate)

Snippet

Sponsor: Kowa Company, Ltd. | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED